Redeye: Vertiseit - Strong Q3 as Expected
Redeye retains its positive view of Vertiseit following a solid Q3 matching our expectations. The momentum in sales is broad, including many sectors, markets, partners, and customers. Vertiseit has also signed several new partners in the US market. We leave our Base Case and forecasts unchanged.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/